CPT® Code 38243

1. Indications

The procedure of administering a hematopoietic progenitor cell (HPC) boost is indicated for patients who exhibit specific complications following an initial HPC transplant. These indications include:

• Poor graft function - This condition occurs when the transplanted stem cells do not adequately produce blood cells, leading to insufficient hematopoiesis.
• Graft failure - This refers to the complete inability of the transplanted cells to engraft and function within the recipient's body, resulting in a lack of blood cell production.
• Graft rejection - This situation arises when the recipient's immune system recognizes the transplanted cells as foreign and mounts an immune response against them, leading to the destruction of the graft.

2. Procedure

The procedure for administering an HPC boost involves several critical steps to ensure the safe and effective infusion of additional hematopoietic stem cells. These steps include:

• Step 1: Patient Assessment - Prior to the infusion, a thorough assessment of the patient's current health status and the functionality of the initial graft is conducted. This may involve laboratory tests to evaluate blood cell counts and overall hematologic function.
• Step 2: Cell Collection - If additional stem cells are required, they may be collected from the same source as the initial transplant, which could be the patient's own bone marrow or peripheral blood, or from a donor if allogeneic cells are needed. This collection process is performed in a separate procedure and is documented accordingly.
• Step 3: Preparation for Infusion - The collected stem cells are processed and prepared for infusion. This may involve washing the cells and ensuring they are in a suitable solution for intravenous administration.
• Step 4: Infusion of HPC Boost - The prepared hematopoietic progenitor cells are infused intravenously into the patient. This procedure is typically performed in a controlled clinical setting, such as a hospital or specialized infusion center, where the patient can be monitored for any immediate reactions.
• Step 5: Post-Infusion Monitoring - After the infusion, the patient is closely monitored for any adverse reactions or complications. This includes checking vital signs and conducting follow-up blood tests to assess the engraftment of the newly infused cells.

3. Post-Procedure

Following the administration of an HPC boost, patients are expected to undergo a period of monitoring to evaluate the effectiveness of the infusion. This includes regular blood tests to assess hematologic recovery and the function of the graft. Patients may also require supportive care to manage any side effects or complications that arise from the infusion. It is essential to provide education on signs of potential graft rejection or other complications, ensuring that patients and caregivers are aware of when to seek further medical attention. The overall recovery process may vary depending on the individual patient's response to the boost and their underlying health status.